Where does Humabs BioMed SA rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Humabs BioMed SA ranks #8,606 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Humabs BioMed SA hold?

Humabs BioMed SA holds 37 US utility patents granted between 2016 and 2025, spanning 7 technology areas.

What is Humabs BioMed SA's Innovation Score?

Humabs BioMed SA has an Innovation Score of 42.5 out of 100 (top 30% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Humabs BioMed SA focus on?

Humabs BioMed SA's top technology area is C07K (Peptides) with 37 patents, ranking #259 of 3,615 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Humabs BioMed SA's patent grant rate increasing or decreasing?

Humabs BioMed SA's recent grant velocity is +156% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Humabs BioMed SA's patents?

Humabs BioMed SA's patents average 23.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Humabs BioMed SA patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Humabs BioMed SA

USPTO PatentsView assignee record - 37 granted patents across 7 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Humabs ranks #8,606 of 49,997 tracked US assignees by granted-patent volume, with 37 patents across 7 technology areas.

#8,606
of 49,997 US assignees by volume: Top 30%
by Innovation Score (42.5/100): 23.2
avg claims per patent: +156%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8606 · Foreign Corporation #8,606 · 37 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 37 grants
UPPER-Q #8,606/49,997
PHOTO-FINISH Hartmetall-Werkzeugf…
CPC-NARROW C07K · 7 areas
INNOV-PAR 42.5/100
CLAIMS-DENSE 23.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +156% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Hartmetall-Werkzeugfabrik Paul Horn GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Humabs’s 42.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.6 pts (30%) Velocity 6.7 pts (16%) Breadth 9.4 pts (22%) Claim depth 13.9 pts (33%)

Qualcomm Incorporated · highest

85
Arc Suppression · near

43
Edatanetworks · near

43
Humabs BioMed · this assignee

43
Pavestone · near

43
Recurium IP Holdings · near

43
3D Lighting… · lowest

7

What this shows Humabs's Innovation Score is 42.5/100 (top 30% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Humabs?

Each dot is one of Humabs’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Humabs’s own 23.2 claims/patent is ABOVE the 14.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Humabs vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Humabs's grants concentrate

Humabs BioMed SA is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2021 (6 grants) versus a trough of 1 in 2016. By volume, Humabs sits between HSNi, LLC and ILI Technology Corp..

Humabs's three-year grant acceleration

Humabs BioMed SA shows 14 grants in 2022–2024 against only 14 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Hsni

37
Hartmetall-werkze…

37
Hatch

37
House of Atlas

37
Hutzler Manufactu…

37
IBC Pharmaceutica…

37
Idex Biometrics A…

37
ILI Technology

37
Humabs Biomed ◀

37

What this shows Humabs holds 37 patents at rank #8,606, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Humabs

By rank, the assignees closest to #8,606 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Humabs's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Humabs, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), Humabs ranks #259 of 3,615 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (43 here).

Pavestone, LLC 43 Arc Suppression Technologies 43 Edatanetworks Inc 43 Recurium IP Holdings, LLC 43

Humabs's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 30% higher than 70% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Humabs BioMed SA patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	2.7%
2018	3	8.1%
2019	5	13.5%
2020	3	8.1%
2021	6	16.2%
2022	4	10.8%
2023	4	10.8%
2024	6	16.2%
2025partial year	5	13.5%

Which technologies does Humabs BioMed SA patent most?

C07K - Peptides 37

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 37

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 35

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 17

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 17

Y02A - Technologies FOR Adaptation TO Climate Change 8

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 3

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Humabs BioMed SA's patent record in context - here's where to go next.

Humabs BioMed SA's lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #8,606 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Humabs BioMed SA against HSNi, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.